Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3707PDF: 2593HTML: 1615 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9316PDF: 6197HTML: 88069Fig.1b: 220Fig.1c: 222Fig.2a: 205Fig.2b: 203Fig.4: 225Fig.2c: 204Fig.3: 208Tab.1: 261Tab.2: 239Tab.3: 223Tab.4: 254Fig1a: 219 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2994PDF: 1318HTML: 2834Figure 1: 199 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3489PDF: 1332HTML: 2310Fi.1 Gritti.Rambaldi: 231 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3522PDF: 820HTML: 3022Figure 1a and 1b: 170Figure 2: 178Figure 3: 197Figure 4: 177Figure 5: 182Tables 1-5: 166 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4312PDF: 1983HTML: 5509Table 1: 234 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5728PDF: 1565HTML: 1661Untitled: 257 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2374PDF: 1361HTML: 17203Bassan Fig.1: 159Bassan Fig.2: 261Bassan Fig.4: 153Fig.3: 225 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4552PDF: 3734HTML: 373 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1998PDF: 819HTML: 576 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1740PDF: 1137HTML: 167 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1472PDF: 854HTML: 3136 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2691PDF: 1673HTML: 2450Table1: 212 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1354PDF: 615HTML: 4118 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2290PDF: 2111HTML: 216 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2451PDF: 1031HTML: 1657Fig 1: 210Tab I: 237Cover Letter: 234 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3843PDF: 1647HTML: 853Figures . Eliassian: 253 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1402PDF: 486HTML: 18624Figure 1: 185Figure 2: 165Figure 3: 183Figure 4: 219Figure 5: 194 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1085PDF: 957Suppl. Files: 611HTML: 104 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1596PDF: 941HTML: 2010Figure: 197Tables: 208ALL revision 1: 292response to reviewer: 201 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3863PDF: 1686HTML: 88 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2569PDF: 1734HTML: 518 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1274PDF: 625HTML: 6918 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2138PDF: 882HTML: 360 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2301PDF: 850HTML: 1697Figure 1: 224Table 1: 236 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1422PDF: 614Suppl. Files: 369HTML: 173 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1377PDF: 546HTML: 294 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1663PDF: 680HTML: 1392 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2219PDF: 1036HTML: 4092Cover Letter: 241Figure 1: 255Figure 2: 248Table 1: 229 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2288PDF: 752HTML: 2144Untitled: 247Untitled: 170Untitled: 201Untitled: 174Untitled: 192Untitled: 200Untitled: 205







